[IMCAS World 2026 Special] Shaping the Future: K-Medical Aesthetics Leading Innovation ⑭ | Interview with Dr. Jeongwoo Lee, KOL for PRX-PLUS
In the expanding skin booster market, the question of how to deliver active ingredients deep into the skin without needles remains a central challenge. PRX-PLUS by WiQo offers a distinct approach — a topical formulation in which ATCA (Ammonium Trichloroacetate) and Homocysteic Acid work in synergy to penetrate the dermis without frosting, stimulating fibroblast proliferation and new collagen synthesis. Dr. Jeongwoo Lee, Director of ELEV Clinic in Seoul and a global KOL for WiQo, presented his clinical experience with PRX-PLUS at the WiQo Symposium during IMCAS World Congress 2026. In an exclusive interview, he highlighted the product's versatility across all skin types and its seamless compatibility with virtually any combination protocol. "PRX-PLUS delivers its active ingredients effectively through topical application alone, and its ability to be combined with any procedure is its greatest advantage," Dr. Lee noted, adding that "with thin and sensitive skin, the results are actually even better."
#MedicalAestheticNews #IMCAS2026 #PRXPLUS #WiQo #DrJeongwooLee #ELEVClinic #KMedicalAesthetics
★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11243

Comments
Post a Comment